Cape Investment Advisory’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-68
Closed -$5.71K 1219
2025
Q1
$5.71K Sell
68
-19
-22% -$1.77K ﹤0.01% 716
2024
Q4
$8.02K Hold
87
﹤0.01% 629
2024
Q3
$8.08K Hold
87
﹤0.01% 605
2024
Q2
$7.16K Buy
87
+65
+295% +$4.78K ﹤0.01% 585
2024
Q1
$1.46K Buy
+22
New +$1.36K ﹤0.01% 806

Other funds holding LMAT

Cape Investment Advisory's LMAT Position: Q2 2025 in Review

Cape Investment Advisory sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 68 shares — an estimated $5.71K sold.

Cape Investment Advisory first reported a position in LMAT in Q1 2024 and held it in 5 quarters. The position peaked at $8.08K in Q3 2024. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • Cape Investment Advisory reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
  • Cape Investment Advisory sold 68 LeMaitre Vascular shares in Q2 2025, an estimated $5.71K.
  • Cape Investment Advisory first reported a position in LeMaitre Vascular in Q1 2024 and held it in 5 quarters.
  • Cape Investment Advisory's LeMaitre Vascular position peaked at $8.08K in Q3 2024.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Cape Investment Advisory's 13F filing for Q2 2025, filed 19 Aug 2025.